ARTICLE | Clinical News
Corvas reports preliminary Phase II data
June 20, 2000 7:00 AM UTC
CVAS completed enrollment of 292 patients in its international Phase II trial of rNAPc2 injectable anticoagulant to prevent deep vein thrombosis (DVT) in orthopedic surgery. Preliminary results showed...